EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blood 1‐Deoxysphingolipid Levels Are Associated With Epidermal Denervation in Small Fiber Neuropathy

Luisa Kreß, Caren Meyer Zu Altenschildesche, Nadine Egenolf, Claudia Sommer, Thorsten Hornemann, Nurcan Üçeyler

Journal of the Peripheral Nervous System · 2025

DOI: 10.1111/jns.70089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, 2025. Verfasst von Luisa Kreß und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: Small Fiber Neuropathy, Epidermis, Sphingolipids. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, European Joint Program on Rare Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Dysfunctional sphingolipid metabolism leads to nerve fiber degeneration, particularly of small caliber Aδ and C fibers, in hereditary sensory and autonomic neuropathies. We aimed to investigate the association of blood 1‐deoxysphingolipid (1‐deoxySL) profiles and skin denervation in idiopathic small fiber neuropathy (SFN).

Methods

Seventy‐five patients with idiopathic SFN were recruited prospectively. Patients underwent a skin punch biopsy at the lower leg and upper thigh for intraepidermal nerve fiber density (IENFD) quantification. IENFD was correlated with individual blood 1‐deoxySL levels, amino acid profiles, and determinants of glucose and lipoprotein metabolism.

Results

Median distal IENFD in SFN patients was 5.3 fibers/mm. In 38/75 (51%) patients, IENFD was ≤ 5.3 fibers/mm (i.e., “low fiber density,” LFD), while in 37/75 (49%) patients, IENFD was > 5.3 fibers/mm (i.e., “high fiber density,” HFD). 1‐deoxySL was higher in patients with LFD compared to HFD ( p < 0.05). Fasting plasma glucose was also higher in patients with LFD than in patients with HFD ( p < 0.01), while HDL was lower in patients with LFD compared to HFD ( p < 0.001).

Interpretation

1‐deoxySL, lipoprotein metabolism, and glucose levels are associated with the extent of epidermal denervation in SFN, supporting the role of this metabolic axis in small nerve fiber pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Fiber NeuropathyEpidermisSphingolipidsHumansMaleFemaleMiddle AgedAgedAdultNerve FibersProspective Studies

Stichwörter der Autor:innen

epidermal denervationlipoproteinssmall fiber neuropathysphingolipids

Substanzen

Sphingolipids

Autor:innen und Institutionen

  • Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
  • Department of Biochemistry, University of Zurich, Zurich, Switzerland.

Förderung

  • Deutsche Forschungsgemeinschaft
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • European Joint Program on Rare Diseases

Zitieren

APA

Kreß, L., Meyer Zu Altenschildesche, C., Egenolf, N., Sommer, C., Hornemann, T., & Üçeyler, N. (2025). Blood 1‐Deoxysphingolipid Levels Are Associated With Epidermal Denervation in Small Fiber Neuropathy. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70089

Vancouver

Kreß L, Meyer Zu Altenschildesche C, Egenolf N, Sommer C, Hornemann T, Üçeyler N. Blood 1‐Deoxysphingolipid Levels Are Associated With Epidermal Denervation in Small Fiber Neuropathy. Journal of the Peripheral Nervous System. 2025. doi:10.1111/jns.70089

BibTeX
@article{Kre2025,
  author = {Kreß, Luisa and Meyer Zu Altenschildesche, Caren and Egenolf, Nadine and Sommer, Claudia and Hornemann, Thorsten and Üçeyler, Nurcan},
  title = {Blood 1‐Deoxysphingolipid Levels Are Associated With Epidermal Denervation in Small Fiber Neuropathy},
  journal = {Journal of the Peripheral Nervous System},
  year = {2025},
  doi = {10.1111/jns.70089}
}
Kostenlos starten →